Literature DB >> 15812301

Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons.

Lee A Ligon1, Bernadette H LaMonte, Karen E Wallace, Nicholas Weber, Robert G Kalb, Erika L F Holzbaur.   

Abstract

Cytoplasmic dynein and dynactin drive retrograde axonal transport in neurons, and mutations in dynein/dynactin cause motor neuron degeneration. To test whether defects in dynein/dynactin function are involved in the neurodegenerative disease amyotrophic lateral sclerosis, we examined neurotracer transport from muscle to motor neuron in a transgenic mouse model of amyotrophic lateral sclerosis. Significant inhibition was observed, which was temporally correlated with declines in muscle strength. No decrease in dynein/dynactin expression was observed, but immunohistochemistry suggests that dynein associates with aggregates of mutant Cu/Zn superoxide dismutase 1. Expression of mutant Cu/Zn superoxide dismutase 1 in primary motor neurons altered the cellular localization of dynein, suggesting an inhibition of dynein/dynactin function. Thus, inhibition of dynein/dynactin function may have a role in motor neuron degeneration in amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812301     DOI: 10.1097/00001756-200504250-00002

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  47 in total

1.  A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction.

Authors:  Xiaohu Tang; Kathleen I Seyb; Mickey Huang; Eli R Schuman; Ping Shi; Haining Zhu; Marcie A Glicksman
Journal:  J Biomol Screen       Date:  2011-12-01

2.  Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice.

Authors:  Yi-Bing Zhu; Zu-Hang Sheng
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 3.  Retrograde axonal transport: pathways to cell death?

Authors:  Eran Perlson; Sandra Maday; Meng-Meng Fu; Armen J Moughamian; Erika L F Holzbaur
Journal:  Trends Neurosci       Date:  2010-04-29       Impact factor: 13.837

Review 4.  TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities.

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Neurobiol Dis       Date:  2018-05-28       Impact factor: 5.996

Review 5.  Neuroproteomics approaches to decipher neuronal regeneration and degeneration.

Authors:  Faneng Sun; Valeria Cavalli
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

Review 6.  Mitochondrial dysfunction in amyotrophic lateral sclerosis.

Authors:  Ping Shi; Jozsef Gal; David M Kwinter; Xiaoyan Liu; Haining Zhu
Journal:  Biochim Biophys Acta       Date:  2009-08-26

Review 7.  Retrograde axonal transport and motor neuron disease.

Authors:  Anna-Lena Ström; Jozsef Gal; Ping Shi; Edward J Kasarskis; Lawrence J Hayward; Haining Zhu
Journal:  J Neurochem       Date:  2008-04-01       Impact factor: 5.372

8.  Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.

Authors:  Anna-Lena Ström; Ping Shi; Fujian Zhang; Jozsef Gal; Renee Kilty; Lawrence J Hayward; Haining Zhu
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

9.  Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Lynsey G Bilsland; Albert R La Spada; Michael G Hanna; Giampietro Schiavo; Jean-Marc Gallo; Linda Greensmith
Journal:  Hum Mol Genet       Date:  2011-02-11       Impact factor: 6.150

10.  Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

Authors:  Jordi Magrané; Isabel Hervias; Matthew S Henning; Maria Damiano; Hibiki Kawamata; Giovanni Manfredi
Journal:  Hum Mol Genet       Date:  2009-09-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.